ethosuximide has been researched along with Colicky Pain in 2 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This clinical study aimed to assess the adjunct role of ethosuximide, an antiepileptic drug with T-type calcium channel blocking activity, in the relieving of IBS-related abdominal pain." | 9.51 | Open-label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome. ( Bahaa, MM; El-Haggar, SM; Hegazy, SK; M Abd-Elsalam, S, 2022) |
| " It is the first clinical trial evaluating the efficacy and safety of ethosuximide on abdominal pain related to IBS." | 9.24 | Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial. ( Ardid, D; Dapoigny, M; Kerckhove, N; Pereira, B; Scanzi, J, 2017) |
| " This clinical study aimed to assess the adjunct role of ethosuximide, an antiepileptic drug with T-type calcium channel blocking activity, in the relieving of IBS-related abdominal pain." | 5.51 | Open-label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome. ( Bahaa, MM; El-Haggar, SM; Hegazy, SK; M Abd-Elsalam, S, 2022) |
| " It is the first clinical trial evaluating the efficacy and safety of ethosuximide on abdominal pain related to IBS." | 5.24 | Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial. ( Ardid, D; Dapoigny, M; Kerckhove, N; Pereira, B; Scanzi, J, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Haggar, SM | 1 |
| Hegazy, SK | 1 |
| M Abd-Elsalam, S | 1 |
| Bahaa, MM | 1 |
| Kerckhove, N | 1 |
| Scanzi, J | 1 |
| Pereira, B | 1 |
| Ardid, D | 1 |
| Dapoigny, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Comparative Study to Assess Safety and Effectiveness of Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome[NCT04217733] | Phase 3 | 60 participants (Anticipated) | Interventional | 2019-11-01 | Recruiting | ||
| Evaluation of the Efficacy and Tolerance of Ethosuximide in the Treatment of Abdominal Pain Associated With Irritable Bowel Syndrome[NCT02973542] | Phase 2 | 162 participants (Actual) | Interventional | 2018-04-30 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for ethosuximide and Colicky Pain
| Article | Year |
|---|---|
Open-label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome.
Topics: Abdominal Pain; Ethosuximide; Humans; Irritable Bowel Syndrome; Pilot Projects; Prospective Studies; | 2022 |
Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial.
Topics: Abdominal Pain; Chronic Pain; Double-Blind Method; Ethosuximide; France; Humans; Irritable Bowel Syn | 2017 |